Condition: ALD (Adrenoleukodystrophy) · Adrenoleukodystrophy · Cerebral Adrenoleukodystrophy · Sponsor: Masonic Cancer Center, University of Minnesota
The aim of this registry to understand the natural history and disease progression in ALD and potentially develop bio-markers using the biospecimens collected using this registry.
This description comes directly from the study's public registry record.
Ashish Gupta, MD · 612-626-2961 · gupta461@umn.edu
Paul Orchard, MD · 612-626-2961 · orcha001@umn.edu
Always discuss trial participation with your own doctor first.
| Masonic Cancer Center at University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03789721